BCA
GILD icon

Bay Colony Advisors’s Gilead Sciences GILD Stock Holding History

Bay Colony Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$491K Sell
3,883
-105
-3% -$13.8K 0.05% 264
2026
Q1 		$556K Buy
3,988
+65
+2% +$9.1K 0.07% 238
2025
Q4 		$482K Buy
3,923
+158
+4% +$19.2K 0.06% 288
2025
Q3 		$418K Sell
3,765
-41
-1% -$4.66K 0.05% 322
2025
Q2 		$422K Sell
3,806
-114
-3% -$12.1K 0.06% 278
2025
Q1 		$438K Buy
3,920
+57
+1% +$5.88K 0.07% 264
2024
Q4 		$357K Buy
3,863
+21
+0.5% +$1.89K 0.05% 295
2024
Q3 		$322K Buy
3,842
+10
+0.3% +$763 0.05% 307
2024
Q2 		$263K Buy
3,832
+12
+0.3% +$801 0.04% 325
2024
Q1 		$280K Sell
3,820
-1,318
-26% -$101K 0.05% 302
2023
Q4 		$416K Buy
5,138
+1,099
+27% +$85.5K 0.08% 227
2023
Q3 		$303K Sell
4,039
-2,802
-41% -$216K 0.07% 235
2023
Q2 		$527K Buy
6,841
+1,122
+20% +$89.5K 0.13% 162
2023
Q1 		$466K Buy
5,719
+546
+11% +$45.2K 0.12% 170
2022
Q4 		$444K Buy
5,173
+1,273
+33% +$101K 0.12% 179
2022
Q3 		$241K Buy
3,900
+49
+1% +$3.09K 0.07% 266
2022
Q2 		$230K Buy
3,851
+452
+13% +$28K 0.06% 293
2022
Q1 		$202K Sell
3,399
-1,729
-34% -$111K 0.05% 337
2021
Q4 		$372K Buy
5,128
+183
+4% +$12.6K 0.11% 227
2021
Q3 		$345K Sell
4,945
-4,322
-47% -$304K 0.11% 218
2021
Q2 		$638K Sell
9,267
-2,757
-23% -$184K 0.21% 135
2021
Q1 		$777K Sell
12,024
-2,260
-16% -$146K 0.3% 105
2020
Q4 		$832K Sell
14,284
-892
-6% -$53.8K 0.44% 73
2020
Q3 		$959K Sell
15,176
-1,137
-7% -$78.8K 0.6% 58
2020
Q2 		$1.25M Buy
16,313
+4,530
+38% +$347K 0.91% 25
2020
Q1 		$881K Buy
11,783
+4,697
+66% +$325K 0.8% 37
2019
Q4 		$449K Buy
7,086
+2,053
+41% +$134K 0.29% 123
2019
Q3 		$319K Buy
+5,033
New +$329K 0.22% 167
2018
Q3 		– Sell
-1,859
Closed -$132K – 460
2018
Q2 		$132K Buy
+1,859
New +$131K 0.09% 203

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bay Colony Advisors's GILD Position: Q2 2026 in Review

Bay Colony Advisors reduced its Gilead Sciences (GILD) stake by 2.6% in Q2 2026, selling an estimated $13.8K and leaving 3,883 shares worth $491K. The position accounts for 0.05% of the portfolio, ranked #264.

Bay Colony Advisors first reported a position in GILD in Q2 2018 and has held it in 29 quarters since. The position peaked at $1.25M in Q2 2020. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Bay Colony Advisors held 3,883 shares of Gilead Sciences worth $491K as of Q2 2026.
  • Bay Colony Advisors sold 105 Gilead Sciences shares in Q2 2026, an estimated $13.8K.
  • Gilead Sciences made up 0.05% of Bay Colony Advisors's portfolio in Q2 2026, its #264 holding.
  • Bay Colony Advisors first reported a position in Gilead Sciences in Q2 2018 and has held it in 29 quarters since.
  • Bay Colony Advisors's Gilead Sciences position peaked at $1.25M in Q2 2020.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bay Colony Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.